Your browser doesn't support javascript.
Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
Goga, Ameena; Bekker, Linda-Gail; Garrett, Nigel; Reddy, Tarylee; Yende-Zuma, Nonhlanhla; Fairall, Lara; Moultrie, Harry; Takalani, Azwidihwi; Trivella, Valentina; Faesen, Mark; Bailey, Veronique; Seocharan, Ishen; Gray, Glenda E.
  • Goga A; HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town 7505, South Africa; University of Pretoria, Pretoria, South Africa. Electronic address: ameena.goga@mrc.ac.za.
  • Bekker LG; Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Garrett N; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa; School of Nursing and Public Health, Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Reddy T; Biostatistics Research Unit, South African Medical Research Council, Cape Town 7505, South Africa.
  • Yende-Zuma N; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Fairall L; Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; King's Global Health Institute, King's College London, London, UK.
  • Moultrie H; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Takalani A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Trivella V; Right to Care, Johannesburg, South Africa.
  • Faesen M; Right to Care, Johannesburg, South Africa.
  • Bailey V; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Seocharan I; Biostatistics Research Unit, South African Medical Research Council, Cape Town 7505, South Africa.
  • Gray GE; Office of the President and CEO, South African Medical Research Council, Cape Town 7505, South Africa.
Lancet ; 400(10348): 269-271, 2022 07 23.
Article in English | MEDLINE | ID: covidwho-1915109
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Lancet Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Lancet Year: 2022 Document Type: Article